XML 49 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Reconciliation Of Earnings Per Common And Diluted Share
The computations of basic and diluted earnings per common share were as follows:
EARNINGS PER SHARE COMPUTATIONS
 Three Months Ended
June 30,
Six Months Ended
June 30,
(Dollars in millions, except per share data; shares in thousands)2023202220232022
Net income $329 $177 $585 $374 
Net income attributable to noncontrolling interest4 9 
Net income attributable to controlling interest325 174 576 368 
Preferred stock dividends8 16 16 
Net income available to common shareholders$317 $166 $560 $352 
Weighted average common shares outstanding—basic539,120 534,604 538,035 533,915 
Effect of dilutive restricted stock, performance equity awards and options3,100 7,319 4,956 7,223 
Effect of dilutive convertible preferred stock (a)18,658 27,512 19,197 18,696 
Weighted average common shares outstanding—diluted560,878 569,435 562,188 559,834 
Basic earnings per common share$0.59 $0.31 $1.04 $0.66 
Diluted earnings per common share$0.56 $0.29 $1.00 $0.63 
(a) On February 28, 2022, FHN issued $494 million of Series G Convertible Preferred Stock, which was converted into common stock on June 26, 2023, following the termination of the TD Merger Agreement. Conversion occurred at the rate of 4,000 common shares per Series G preferred share resulting in 19,742,776 additional common shares outstanding. 2023 includes the impact of the Series G based on the final conversion rate and 2022 includes the impact based on the original maximum conversion rate. For more information on the convertible features, including the conversion rate, see Note 7 - Preferred Stock.
Schedule of Anti-Dilutive Options and Awards
The following table presents average outstanding options and other equity awards that were excluded from the calculation of diluted earnings per share because they were either anti-dilutive (the exercise price was higher
than the weighted-average market price for the period) or the performance conditions have not been met:
ANTI-DILUTIVE EQUITY AWARDS
 Three Months Ended
June 30,
Six Months Ended
June 30,
(Shares in thousands)2023202220232022
Stock options excluded from the calculation of diluted EPS1,942 23  48 
Weighted average exercise price of stock options excluded from the calculation of diluted EPS$16.46 $27.88 $24.36 $25.60 
Other equity awards excluded from the calculation of diluted EPS8,676 1,892 3,063 1,231